Go to content
UR Home

Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease

URN to cite this document:
DOI to cite this document:
Lebek, Simon ; Tafelmeier, Maria ; Messmann, Rebecca ; Provaznik, Zdenek ; Schmid, Christof ; Maier, Lars S. ; Birner, Christoph ; Arzt, Michael ; Wagner, Stefan
License: Creative Commons Attribution Non-commercial 4.0
PDF - Published Version
Date of publication of this fulltext: 26 Jan 2021 16:19

This publication is part of the DEAL contract with Wiley.


Aims Coronavirus disease 2019 (COVID-19) is a widespread pandemic with an increased morbidity and mortality, especially for patients with cardiovascular diseases. Angiotensin-converting enzyme 2 (ACE2) has been identified as necessary cell entry point for SARS-CoV-2. Previous animal studies have demonstrated an increased ACE2 expression following treatment with either angiotensin-converting ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons